What Has Been the Progress and Growth of the Zoonotic Disease Treatment Market in Recent Years?
The zoonotic disease treatment market has seen considerable growth due to a variety of factors.
• The zoonotic disease treatment market has seen strong growth in recent years. It will rise from $39.71 billion in 2024 to $42.64 billion in 2025, at a CAGR of 7.4%.
This increase is due to the emergence of major zoonotic outbreaks, urbanization and habitat encroachment, the One Health approach, increased surveillance and reporting, and greater public awareness and education.
What Is The Expected Growth In The Zoonotic Disease Treatment Market Size Evolve over the Forecast Period?
The zoonotic disease treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The zoonotic disease treatment market is expected to grow strongly, reaching $55.92 billion by 2029 at a CAGR of 7.0%.
This growth is driven by climate change, increased government and international funding, advances in medical technology, regulatory support, and collaborative R&D. Trends include the development of broad-spectrum antivirals, strengthening global health infrastructure, diagnostic technology advancements, growth in vaccine development platforms, and an emphasis on preventive measures.
What Main Forces Are Fueling Expansion In The Zoonotic Disease Treatment Market?
The surge in the need for animal proteins is poised to boost the zoonotic disease treatment market's expansion going forward. Originating from sources like meat, dairy, eggs, and fish, animal proteins encompass all vital amino acids essential for human health. Various factors, including the swelling global populace, improved income levels, urbanization, and an increase in cognizance about the nutritional gains of animal-based foods, are contributing to the escalated demand for animal proteins. Treatments for zoonotic diseases emerge as crucial in controlling illnesses that originate from animal proteins, understanding transmission paths, formulating effective treatments, and adopting preventive actions to lessen public health threats. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization revealed that the global meat consumption, as per a US-based agricultural commodity market, is set to augment annually at a rate of 0.1%. The growth is mainly propelled by escalating demand in middle and lower-income countries, with poultry likely to make up nearly half of the total surge in meat production by 2032. Therefore, the amplified demand for animal proteins accounts for the driving force behind the growth of the zoonotic disease treatment market.
What Are The Primary Segments In The Global Zoonotic Disease Treatment Market?
The zoonotic disease treatment market covered in this report is segmented –
1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment
3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment
6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya
Pre-Book The Zoonotic Disease Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Zoonotic Disease Treatment Market?
Leading organizations within the zoonotic disease treatment market are emphasizing on investments in the same to improve diagnostic efficiencies and enhance treatment procedures. This involves creating sophisticated diagnostic technologies like PCR kits, which enable faster detection of zoonotic pathogens and allow the implementation of specific therapeutic interventions. For instance, in October 2023, BioPerfectus, a biotechnology firm from China that specializes in diagnostic solutions, has expanded its Zoonotic Infectious Diseases Total PCR Solution by adding thirteen new members. This move is meant to strengthen its diagnostic capacities for zoonotic ailments, responsible for more than 60% of identified infectious illnesses and 75% of emerging infections. This strategic step is expected to elevate health security readiness and response, especially as climate change drives the migration of infectious diseases to new areas. Through these novel products, the company's objective is to expedite diagnosis and improve zoonotic infection management, underlining the significance of preventive public health steps.
Who Are the Key Players In The Zoonotic Disease Treatment Market?
Major companies operating in the zoonotic disease treatment market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck And Co. Inc.
• Bayer AG
• Sanofi S.A.
• AstraZeneca plc
• Novartis International AG
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• IDEXX Laboretories Inc.
• Hikma Pharmaceuticals PLC.
• Ceva Santé Animale
• Vir Biotechnology Inc.
• Virbac
• Vetoquinol S.A.
• BioCryst Pharmaceuticals Inc.
• Heska Corporation
What Is The Most Dominant Region In The Zoonotic Disease Treatment Market?
North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
